Mycophenolate-Sodium is an immunosuppressant medicine used to prevent rejection in patients who have undergone organ transplants, like kidney, heart, or liver. It works by reducing the activity of the immune system, which helps to prevent the body from rejecting the transplanted organ.
Unlike Mycophenolate Mofetil, which is an ester prodrug that is rapidly hydrolyzed to its active form, Mycophenolate-Sodium is a salt form that does not need hydrolysis and is more stable than Mycophenolate Mofetil.
The medication is generally taken orally as a tablet or capsule, with or without food, according to the patient’s prescription. Mycophenolate-Sodium can have several side effects, like diarrhea, vomiting, nausea, headaches, and stomach pain, and may increase the risk of developing infections and certain types of cancers.
Therefore, patients taking this medication should be closely monitored by their healthcare providers.